Fair Value Assets Liabilities Transfer Between Levels

No definition available.

Name:	ebio_FairValueAssetsLiabilitiesTransferBetweenLevels
Namespace Prefix:	ebio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Fair Value Changes In Valuation Techniques

+ References

No definition available.

+ Details

Name:	ebio_FairValueChangesInValuationTechniques
Namespace Prefix:	ebio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Share Purchase Agreement, One-Time Milestone Payment Upon First Sale of Product

+ References

No definition available.

+ Details

Name:	ebio_SharePurchaseAgreementOneTimeMilestonePaymentUponFirstSaleofProduct
Namespace Prefix:	ebio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Share Purchase Agreement, Percentage of Net Sales of Quarterly Earn-Out Payments During Earn-Out Periods

+ References

No definition available.

+ Details

Name:	ebio_SharePurchaseAgreementPercentageofNetSalesofQuarterlyEarnOutPaymentsDuringEarnOutPeriods
Namespace Prefix:	ebio_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Share Purchase Agreement, Period During Which Quarterly Earn-Outs are Payable After Date of Net Sales

+ References

No definition available.

+ Details

Name:	ebio_SharePurchaseAgreementPeriodDuringWhichQuarterlyEarnOutsarePayableAfterDateofNetSales
Namespace Prefix:	ebio_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueInputsDiscountRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ValuationTechniqueAxis=ebio_ClinicalandCommercialMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CounterpartyNameAxis=ebio_ViventiaBioInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=ebio_CollaborativeArrangementRevenuebasedonSpecifiedMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=ebio_ViciniumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementGeographicalAxis=country_JP
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Fair Value of Financial Instruments - Contingent Consideration (Details) - USD ($)			3 Months Ended	9 Months Ended
	Sep. 20, 2016	Sep. 20, 2014	Sep. 30, 2016	Sep. 30, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Transfer of assets and liabilities between levels			$ 0	$ 0
Changes in valuation methods			$ 0	$ 0
Minimum \| Clinical and Commercial Milestones \| Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount rate (in percentage)				4.40%
Maximum \| Clinical and Commercial Milestones \| Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Discount rate (in percentage)				9.80%
Viventia Bio Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Period during which quarterly earn-outs are payable after date of net sales	15 years	15 years
Viventia Bio Inc. \| Specified Milestone \| Vicinium
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Percentage of net sales of quarterly earn-out payments during earn-out periods	2.00%	2.00%
UNITED STATES \| Viventia Bio Inc. \| Specified Milestone \| Vicinium
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
One-time milestone payment upon first sale of product	$ 12,500,000	$ 12,500,000
Europe \| Viventia Bio Inc. \| Specified Milestone \| Vicinium
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
One-time milestone payment upon first sale of product	7,000,000	7,000,000
JAPAN \| Viventia Bio Inc. \| Specified Milestone \| Vicinium
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
One-time milestone payment upon first sale of product	$ 3,000,000	$ 3,000,000